BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 18783339)

  • 1. Ceramide in bacterial infections and cystic fibrosis.
    Grassmé H; Becker KA; Zhang Y; Gulbins E
    Biol Chem; 2008 Nov; 389(11):1371-9. PubMed ID: 18783339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biological aspects of ceramide-enriched membrane domains.
    Grassmé H; Riethmüller J; Gulbins E
    Prog Lipid Res; 2007; 46(3-4):161-70. PubMed ID: 17490747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ceramide-enriched membrane domains in infectious biology and development.
    Becker KA; Gellhaus A; Winterhager E; Gulbins E
    Subcell Biochem; 2008; 49():523-38. PubMed ID: 18751925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Host defense against Pseudomonas aeruginosa requires ceramide-rich membrane rafts.
    Grassmé H; Jendrossek V; Riehle A; von Kürthy G; Berger J; Schwarz H; Weller M; Kolesnick R; Gulbins E
    Nat Med; 2003 Mar; 9(3):322-30. PubMed ID: 12563314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ceramide and sphingosine in pulmonary infections.
    Seitz AP; Grassmé H; Edwards MJ; Pewzner-Jung Y; Gulbins E
    Biol Chem; 2015 Jun; 396(6-7):611-20. PubMed ID: 25720061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ceramide: physiological and pathophysiological aspects.
    Schenck M; Carpinteiro A; Grassmé H; Lang F; Gulbins E
    Arch Biochem Biophys; 2007 Jun; 462(2):171-5. PubMed ID: 17467652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bacterial infections and ceramide.
    Grassmé H; Becker KA
    Handb Exp Pharmacol; 2013; (216):305-20. PubMed ID: 23563663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ceramide accumulation mediates inflammation, cell death and infection susceptibility in cystic fibrosis.
    Teichgräber V; Ulrich M; Endlich N; Riethmüller J; Wilker B; De Oliveira-Munding CC; van Heeckeren AM; Barr ML; von Kürthy G; Schmid KW; Weller M; Tümmler B; Lang F; Grassme H; Döring G; Gulbins E
    Nat Med; 2008 Apr; 14(4):382-91. PubMed ID: 18376404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TRAIL activates acid sphingomyelinase via a redox mechanism and releases ceramide to trigger apoptosis.
    Dumitru CA; Gulbins E
    Oncogene; 2006 Sep; 25(41):5612-25. PubMed ID: 16636669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Doxorubicin enhances TRAIL-induced cell death via ceramide-enriched membrane platforms.
    Dumitru CA; Carpinteiro A; Trarbach T; Hengge UR; Gulbins E
    Apoptosis; 2007 Aug; 12(8):1533-41. PubMed ID: 17520194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accumulation of ceramide in the trachea and intestine of cystic fibrosis mice causes inflammation and cell death.
    Becker KA; Tümmler B; Gulbins E; Grassmé H
    Biochem Biophys Res Commun; 2010 Dec; 403(3-4):368-74. PubMed ID: 21078296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ceramide-induced cell death in malignant cells.
    Carpinteiro A; Dumitru C; Schenck M; Gulbins E
    Cancer Lett; 2008 Jun; 264(1):1-10. PubMed ID: 18353542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rhinoviruses infect human epithelial cells via ceramide-enriched membrane platforms.
    Grassmé H; Riehle A; Wilker B; Gulbins E
    J Biol Chem; 2005 Jul; 280(28):26256-62. PubMed ID: 15888438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ceramide, membrane rafts and infections.
    Gulbins E; Dreschers S; Wilker B; Grassmé H
    J Mol Med (Berl); 2004 Jun; 82(6):357-63. PubMed ID: 15069600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Raft ceramide in molecular medicine.
    Gulbins E; Kolesnick R
    Oncogene; 2003 Oct; 22(45):7070-7. PubMed ID: 14557812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ceramide-enriched membrane domains.
    Bollinger CR; Teichgräber V; Gulbins E
    Biochim Biophys Acta; 2005 Dec; 1746(3):284-94. PubMed ID: 16226325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acid Sphingomyelinase-Ceramide System in Bacterial Infections.
    Li C; Wang A; Wu Y; Gulbins E; Grassmé H; Zhao Z
    Cell Physiol Biochem; 2019; 52(2):280-301. PubMed ID: 30816675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cystic fibrosis, fatty acid imbalance, ceramide and lipid rafts].
    Chanson M
    Arch Pediatr; 2009 Jun; 16(6):543-5. PubMed ID: 19541078
    [No Abstract]   [Full Text] [Related]  

  • 19. Ceramide in cystic fibrosis.
    Grassmé H; Riethmüller J; Gulbins E
    Handb Exp Pharmacol; 2013; (216):265-74. PubMed ID: 23563661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipids in cystic fibrosis.
    Becker KA; Henry B; Ziobro R; Riethmüller J; Gulbins E
    Expert Rev Respir Med; 2011 Aug; 5(4):527-35. PubMed ID: 21859272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.